Zhejiang Wecome Pharmaceutical Company Limited (SZSE: 300878)
Health Care · Pharmaceuticals · CN
CN¥33.32
-3.98% today · +46.8% 1Y
Zhejiang Wecome Pharmaceutical Company Limited (SZSE: 300878) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $704.09M and employs 535 people.
Over the last twelve months the share price has gained 46.8%, trading between 19.95 and 40.22.
Tweenvest scores Zhejiang Wecome Pharmaceutical Company Limited across four factors: quality 61/100, value 38/100, growth 0/100. Its strongest factor is quality.
300878 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $704.09M
- Revenue (TTM)
- $32.64M
- P/E
- —
- EPS
- -1.49
- Dividend yield
- —
- Beta (5Y)
- 0.57
- 52-week high
- CN¥40.22
- 52-week low
- CN¥19.95
- Avg volume (3M)
- —
- Shares outstanding
- 142.05M
- Employees
- 535
- Next earnings
- —
About Zhejiang Wecome Pharmaceutical Company Limited
Zhejiang Wecome Pharmaceutical Company Limited primarily focuses on the innovation, manufacturing, and distribution of pharmaceutical products. Beyond its core medicinal offerings, the company also provides a range of healthcare items, over-the-counter (OTC) medications, and traditional Chinese remedies. These products are available in numerous formats, including hard and soft capsules, tablets, granules, and pills, among other dosage forms. Established in 2000, the firm, previously known as Zhejiang Weikang Pharmaceutical Co., Ltd., is headquartered in Lishui, China.
- ISIN
- CNE1000047P9
- Founded
- 2000
- Listed since
- Aug 24, 2020
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,249.71 | -0.45% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $272.79 | +0.94% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.65 | -1.25% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.03 | -0.16% |
Figures last refreshed Aug 18, 2026.